BlackRock Health Sciences Trust II (BMEZ) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BlackRock Health Sciences Trust II (BMEZ) has a cash flow conversion efficiency ratio of 0.103x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($78.91 Million) by net assets ($768.57 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BlackRock Health Sciences Trust II (BMEZ) total market value for the company's overall valuation and market capitalisation.
BlackRock Health Sciences Trust II - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how BlackRock Health Sciences Trust II's cash flow conversion efficiency has evolved over time, based on yearly financial data.
BlackRock Health Sciences Trust II Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BlackRock Health Sciences Trust II ranked by their cash flow conversion efficiency. Explore earnings quality score of BlackRock Health Sciences Trust II to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wuxi Xinhongye Wire & Cable Co. Ltd. A
SHE:301310
|
N/A |
|
Infund Holding Co Ltd
SHE:002141
|
0.075x |
|
Inversiones Aguas Metropolitanas SA
SN:IAM
|
0.039x |
|
Shanghai Jiao Yun Group Co Ltd
SHG:600676
|
0.026x |
|
Nobia AB
ST:NOBI
|
-0.026x |
|
Sumavision Technologies
SHE:300079
|
0.016x |
|
Wenzhou Hongfeng Electrical Alloy Co Ltd
SHE:300283
|
0.047x |
|
Shanghai Industrial Development Co Ltd
SHG:600748
|
0.132x |
Annual Cash Flow Conversion Efficiency for BlackRock Health Sciences Trust II (2019–2024)
The table below shows the annual cash flow conversion efficiency of BlackRock Health Sciences Trust II from 2019 to 2024. View BlackRock Health Sciences Trust II stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $768.57 Million | $65.52 Million | 0.085x | +56.59% |
| 2023-12-31 | $588.14 Million | $32.02 Million | 0.054x | +3838.40% |
| 2022-12-31 | $600.20 Million | $-874.04K | -0.001x | +95.77% |
| 2021-12-31 | $625.77 Million | $-21.56 Million | -0.034x | -117.55% |
| 2020-12-31 | $545.94 Million | $107.17 Million | 0.196x | +121.20% |
| 2019-12-31 | $1.64 Billion | $-1.52 Billion | -0.926x | -- |
About BlackRock Health Sciences Trust II
BlackRock Health Sciences Trust II operates in various business sectors.